| Serial Number | 79301540 |
| Word Mark | NORTHWAY GENE THERAPY |
| Filing Date | Wednesday, November 18, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 27, 2022 |
| Registration Number | 6854457 |
| Registration Date | Tuesday, September 27, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 14, 2021 |
| Description of Mark | The mark consists of the wording "NORTHWAY GENE THERAPY" with the "O" in NORTHWAY being represented by the design of a DNA Helix in dark blue and orange, the rest of the wording "NORTHWAY" in dark blue, and the wording "GENE THERAPY" below in orange. The color white represents background and/or transparent areas and is not claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical preparations, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; albuminous preparations for medical purposes, namely, albumin dietary supplements; chemical preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19 |
| Indication of Colors claimed | The color(s) dark blue and orange is/are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "GENE THERAPY" |
| Goods and Services | Scientific and technological services and research and design relating thereto, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of pharmaceutical studies; technological consultancy in the field of development of manufacturing processes for biotechnology products |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 8, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 8, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | UAB "Northway turto valdymas" |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | LT |
| Party Name | UAB "Northway turto valdymas" |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | LT |
| Party Name | UAB "Northway turto valdymas" |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | LT |
| Event Date | Event Description |
| Tuesday, February 7, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, January 18, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, January 18, 2023 | FINAL DISPOSITION PROCESSED |
| Tuesday, December 27, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, September 27, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 27, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, August 24, 2022 | TTAB RELEASE CASE TO TRADEMARKS |
| Wednesday, August 24, 2022 | OPPOSITION TERMINATED NO. 999999 |
| Wednesday, August 24, 2022 | OPPOSITION DISMISSED NO. 999999 |
| Monday, July 4, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Monday, June 13, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 8, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Sunday, February 6, 2022 | REFUSAL PROCESSED BY IB |
| Thursday, January 20, 2022 | OPPOSITION INSTITUTED NO. 999999 |
| Tuesday, January 11, 2022 | OPPOSITION PAPERS RECEIVED AT TTAB |
| Wednesday, January 12, 2022 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
| Wednesday, January 12, 2022 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
| Sunday, December 19, 2021 | NOTIFICATION PROCESSED BY IB |
| Tuesday, December 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 14, 2021 | PUBLISHED FOR OPPOSITION |
| Friday, November 26, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, November 24, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, November 24, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, November 8, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, November 8, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, November 8, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, November 8, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, November 8, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, October 22, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, October 22, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, October 22, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, October 22, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, October 22, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, October 22, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, October 22, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 22, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 22, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 16, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Sunday, May 30, 2021 | REFUSAL PROCESSED BY IB |
| Thursday, May 13, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, May 13, 2021 | REFUSAL PROCESSED BY MPU |
| Tuesday, May 11, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, May 10, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, April 30, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, January 12, 2021 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 8, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 7, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |